Target intelligence / Profile preview

Cytoplasmic linker-associated protein 2 (CLASP2)

Target
CLASP2
Molecular classification
Other, Microtubule-associated protein, Plus-end tracking protein (+TIP)
01

Overview

Cytoplasmic linker-associated protein 2 (CLASP2) is a microtubule-associated protein that specifically tracks and stabilizes the plus ends of dynamic microtubules, regulating their growth and disassembly[3][2]. CLASP2 contains multiple Tumor Overexpression Gene (TOG) domains, which enable it to interact with tubulin at the growing microtubule ends, where it suppresses microtubule catastrophes and can promote rescue events[2][3]. It is involved in several essential cellular processes, including mitosis (specifically at kinetochores), cell migration, regulation of cell polarity, maintenance of cortical microtubules, and membrane transport. CLASP2 also contributes to insulin signaling by modulating glucose transporter (GLUT4) trafficking and links microtubule dynamics to metabolic regulation, especially in adipocytes[1][3]. Dysfunction or altered expression of CLASP2 is associated with impaired cell division, polarity, and migration, processes central to oncogenesis and possibly neurodegenerative pathways[1][2][3]. As of now, it is not considered an established therapeutic target, nor are there known drugs or approved biomarkers that specifically act on CLASP2.

Other names
CLIP-associating protein 2KIAA0627hOrbit2Protein Orbit homolog 2CLIP-associating protein CLASP2Multiple asters (Mast)-like homolog 2
02

Biological functions

Microtubule stabilizationRegulation of microtubule dynamics (including suppression of catastrophe and rescue)Microtubule nucleationCell migrationCell polarityMitosis and kinetochore functionCell cortex localizationRegulation of insulin-stimulated glucose transport
03

Disease associations

Cancer (role in cell proliferation, migration, and mitotic errors)Metabolic regulation (modulation by insulin)Potential role in neurodegenerative diseases (indirect, via cytoskeleton dynamics)

Beyond the preview

Go deeper on Cytoplasmic linker-associated protein 2 (CLASP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytoplasmic linker-associated protein 2 (CLASP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call